297 related articles for article (PubMed ID: 16904418)
21. A phase I, open-label, mass balance study of [(14)C] dacomitinib (PF-00299804) in healthy male volunteers.
Bello CL; Smith E; Ruiz-Garcia A; Ni G; Alvey C; Loi CM
Cancer Chemother Pharmacol; 2013 Aug; 72(2):379-85. PubMed ID: 23760812
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of efficacy, safety and effects on symptoms of androgenization of a generic oral contraceptive containing chlormadinone acetate 2 mg/ethinylestradiol 0.03 mg.
Hadji P; Biskup J; Boekhoff J; Ziller M; Bonn M; Rovati L
Contraception; 2012 Oct; 86(4):359-65. PubMed ID: 22445436
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic profile of 14C-labeled clopidogrel.
Lins R; Broekhuysen J; Necciari J; Deroubaix X
Semin Thromb Hemost; 1999; 25 Suppl 2():29-33. PubMed ID: 10440420
[TBL] [Abstract][Full Text] [Related]
24. Estimating mass balance for inhaled drugs in humans: an example with a VLA-4 antagonist, IVL745.
Rohatagi S; Shah B; Zhang J; Zeng Z; Kirkesseli S; Jensen BK
J Clin Pharmacol; 2004 Apr; 44(4):348-58. PubMed ID: 15051741
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy male volunteers.
Mihara M; Ohnishi A; Tomono Y; Hasegawa J; Shimamura Y; Yamazaki K; Morishita N
Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):223-9. PubMed ID: 8314652
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the effects of chlormadinone acetate-pellet implantation and orchidectomy on benign prostatic hypertrophy in the dog.
Kawakami E; Tsutsui T; Shimizu M; Orima H; Fujita M; Ogasa A
Int J Androl; 1995 Oct; 18(5):248-55. PubMed ID: 8567095
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects.
Slatter JG; Stalker DJ; Feenstra KL; Welshman IR; Bruss JB; Sams JP; Johnson MG; Sanders PE; Hauer MJ; Fagerness PE; Stryd RP; Peng GW; Shobe EM
Drug Metab Dispos; 2001 Aug; 29(8):1136-45. PubMed ID: 11454733
[TBL] [Abstract][Full Text] [Related]
28. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs.
Boothe DM; Perkins J
J Vet Pharmacol Ther; 2008 Dec; 31(6):544-53. PubMed ID: 19000278
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteers.
Blight AR; Henney HR
Clin Ther; 2009 Feb; 31(2):328-35. PubMed ID: 19302905
[TBL] [Abstract][Full Text] [Related]
30. Profile of the progesterone derivative chlormadinone acetate - pharmocodynamic properties and therapeutic applications.
Druckmann R
Contraception; 2009 Apr; 79(4):272-81. PubMed ID: 19272496
[TBL] [Abstract][Full Text] [Related]
31. A model based assessment of redistribution dependent elimination and bioavailability of rifabutin.
Li RC; Narang PK; Poggesi I; Strolin-Benedetti M
Biopharm Drug Dispos; 1996 Apr; 17(3):223-36. PubMed ID: 8983397
[TBL] [Abstract][Full Text] [Related]
32. Effect of chlormadinone acetate versus drospirenone-containing oral contraceptives on the endocrinal features of women with polycystic ovary syndrome: Systematic review and meta-analysis of randomized clinical trials.
Menshawy A; Ismail A; Abdel-Maboud M; El-Din AA; Elgebaly A; Gadelkarim M; Bahbah EI; Abdelghany MF; Samy A; Abbas AM
J Gynecol Obstet Hum Reprod; 2019 Nov; 48(9):763-770. PubMed ID: 30940512
[TBL] [Abstract][Full Text] [Related]
33. Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase III trial with EE/CMA (Belara) and EE/LNG (Microgynon).
Worret I; Arp W; Zahradnik HP; Andreas JO; Binder N
Dermatology; 2001; 203(1):38-44. PubMed ID: 11549798
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
36. Clinical trial: single- and multiple-dose pharmacokinetics of polyethylene glycol (PEG-3350) in healthy young and elderly subjects.
Pelham RW; Nix LC; Chavira RE; Cleveland MV; Stetson P
Aliment Pharmacol Ther; 2008 Jul; 28(2):256-65. PubMed ID: 18462266
[TBL] [Abstract][Full Text] [Related]
37. Safety data and beneficial effects of the combined oral contraceptive ethinylestradiol 0.03 mg/chlormadinone acetate 2 mg (Belara®): a 13-cycle, observational study in routine clinical practice.
Pushparajah DS; Röhm P; Höschen K; Albers D; Nowack C
Clin Drug Investig; 2011; 31(2):121-34. PubMed ID: 21155614
[TBL] [Abstract][Full Text] [Related]
38. Effect of an oral contraceptive with chlormadinone acetate on depressive mood : analysis of data from four observational studies.
Huber JC; Heskamp ML; Schramm GA
Clin Drug Investig; 2008; 28(12):783-91. PubMed ID: 18991472
[TBL] [Abstract][Full Text] [Related]
39. A comparative study of the hemostatic effects of two monophasic oral contraceptives containing 30 mu(g) ethinylestradiol and either 2 mg chlormadinone acetate or 150 mu(g) desogestrel.
Winkler UH; Daume E; Sudik R; Oberhoff C; Bier U; Hallmann C; Andreas JO; Schindler AE
Eur J Contracept Reprod Health Care; 1999 Sep; 4(3):145-54. PubMed ID: 10574640
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of treprostinil sodium administered by 28-day chronic continuous subcutaneous infusion.
Wade M; Baker FJ; Roscigno R; DellaMaestra W; Arneson CP; Hunt TL; Lai AA
J Clin Pharmacol; 2004 May; 44(5):503-9. PubMed ID: 15102871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
